$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Avi Kapoor
$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying. Notable insider purchases were made in Arcus Biosciences, Peoples Financial, and AMREP, indicating confidence in these companies. Gilead Sciences Inc acquired shares of Arcus Biosciences for $320 million. Peoples Financial CEO bought shares worth $81,568. AMREP saw a purchase of $891,020 by Rainey Lancaster.
February 01, 2024 | 11:09 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AMREP Corporation saw a purchase of 44,551 shares by 10% owner Rainey Lancaster at an average price of $20.00, totaling around $891,020.
The substantial purchase by Rainey Lancaster in AMREP suggests optimism about the company's future, potentially leading to a positive short-term impact on AXR stock.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Peoples Financial Corporation CEO, Chevis Swetman, acquired 5,212 shares at an average price of $15.65, costing around $81,568.
The purchase by Peoples Financial's CEO indicates confidence in the company's prospects, potentially leading to a positive short-term impact on PFBX stock.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Gilead Sciences Inc acquired 15,238,095 shares of Arcus Biosciences at $21.00 each, totaling around $320 million.
The significant investment by Gilead Sciences in Arcus Biosciences suggests a strong vote of confidence in the company's future, potentially leading to a positive short-term impact on RCUS stock.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100